Vitiligo

Episodes

Brett King, MD, PhD
November 23, 2022
Dr Brett King: The Algorithm of Treating Vitiligo Is Not Straightforward
A new awareness of vitiligo and new treatments coming to market is providing a multitude of options for treating the disease, said Brett King, MD, PhD, associate professor of dermatology, Yale School of Medicine.
Brett King, MD, PhD
November 11, 2022
First FDA-Approved Therapy for Repigmentation Is a Breakthrough for Vitiligo, Says Dr Brett King
Prior to this first therapy for repigmentation being approved, the only approved therapy was a depigmenting agent, which is usually the opposite of what providers are trying to accomplish with treatment.
David Rosmarin, MD
September 29, 2022
Dr David Rosmarin Discusses the Economic Burden on Patients With Vitiligo
Coverage of vitiligo treatments is variable and patients can face an economic burden in the form of direct and indirect costs, explained David Rosmarin, MD, vice chair, education and research at Tufts Medical Center.
David Rosmarin, MD
September 16, 2022
Vitiligo Burden Is Variable but Can Be High, Dr David Rosmarin Explains
Patients with vitiligo are often impacted mentally, and they can spend a lot of time utilizing cosmetic products, said David Rosmarin, MD, vice chair, education and research at Tufts Medical Center.
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo